Recently, accumulating evidence has shown that HDAC4 overexpression is correlated with the development and progression of cancers, including multiple myeloma, prostate cancer, breast cancer, colon cancer, glioblastoma, and esophageal cancer9–14. The gene discussed is HDAC4; the disease is plasma cell myeloma.